Rehabilitation After Covid19-Clinical Results and Predictive Factors

May 20, 2021 updated by: Stefan Bachmann, Klinik Valens

Rehabilitation After Covid19-Clinical Results and Predictive Factors for Rehabilitation Outcomes

The aim of the study is to gain insight into the rehabilitation process and predictive factors for the outcome after rehabilitation in three patient groups:

  1. SARS-CoV-2-positive patients in the isolation ward
  2. Post-Covid-19 patients
  3. Control group; matched for gender, age and co-morbidity

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

101

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Switzerland
    • SG
      • Valens, SG, Switzerland, CH- 7317
        • Rehabilitationszentrum Klinik Valens

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

All patients referred to rehabilitation between March and June 2020 either with active Covid19, post-Covid-State oor other indications for inpatient rehab (eg. muskuloskelettal, cancer, pulmonary diseases not related to Covid19)

Description

Inclusion Criteria:

  • Patients assigned to rehab
  • Written informed consent

Exclusion Criteria:

  • not able to fill in questionnaires in German

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Other

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Isolation group with active Covid19
Patients assigned to rehab which had to be treated in isolation wards dur to active disease
Other: Rehabilitation
Rehabilitative procedures in isolation ward
Post-Covid-group
Patients assigned to rehab after active disease, still having restrictions in activity and particiaption
Other: Rehabilitation
Rehabilitative procedures in isolation ward
Control group
Pateints assigned to rehabilitation in the same time period without any signs of Sars-coV-2 infection
Other: Rehabilitation
Rehabilitative procedures in isolation ward

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mobility
Time Frame: Measurements done at entry and at discharge of rehabilitation (time between: 4- 6 weeks)
Timed Up and Go-Test TUG (Seconds; less=better, normal <10 Sec.)
Measurements done at entry and at discharge of rehabilitation (time between: 4- 6 weeks)
Functional Independence Measurement-Level (FIM)
Time Frame: Measurements done at entry and at discharge of rehabilitation (time between: 4- 6 weeks)
FIM at entry and discharge (min 18, max 126 points; higher level= better functioning; )
Measurements done at entry and at discharge of rehabilitation (time between: 4- 6 weeks)
Promis-10 (Promis= Patient reported outcome measurement information system)
Time Frame: Measurements done at entry and at discharge of rehabilitation (time between: 4- 6 weeks)
Level of patient self rated functioning in daily activities (higher level= better self related functioning)
Measurements done at entry and at discharge of rehabilitation (time between: 4- 6 weeks)
Quality of life
Time Frame: Measurements done at entry and at discharge of rehabilitation (time between: 4- 6 weeks)
EQ5D- VAS (0-100; higher level = better quality of life)
Measurements done at entry and at discharge of rehabilitation (time between: 4- 6 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Klinik Valens

Investigators

  • Principal Investigator: Steffi Petzold, MMed, Kliniken Valens
  • Principal Investigator: Roisin Carney, PT, cand MSc, Kliniken Valens

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2020

Primary Completion (Actual)

February 28, 2021

Study Completion (Actual)

May 18, 2021

Study Registration Dates

First Submitted

May 19, 2021

First Submitted That Met QC Criteria

May 20, 2021

First Posted (Actual)

May 21, 2021

Study Record Updates

Last Update Posted (Actual)

May 21, 2021

Last Update Submitted That Met QC Criteria

May 20, 2021

Last Verified

May 1, 2021

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Covid19_2020

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe